Magnus Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $757K | Buy |
31,451
+511
| +2% | +$13.4K | 0.05% | 190 |
|
|
2026
Q1 | $869K | Sell |
30,940
-10,128
| -25% | -$270K | 0.07% | 164 |
|
|
2025
Q4 | $1.02M | Buy |
41,068
+10,961
| +36% | +$276K | 0.08% | 171 |
|
|
2025
Q3 | $767K | Sell |
30,107
-6,128
| -17% | -$151K | 0.06% | 192 |
|
|
2025
Q2 | $878K | Sell |
36,235
-6,499
| -15% | -$152K | 0.08% | 171 |
|
|
2025
Q1 | $1.08M | Buy |
42,734
+548
| +1% | +$14.3K | 0.1% | 148 |
|
|
2024
Q4 | $1.12M | Sell |
42,186
-1,890
| -4% | -$51.3K | 0.11% | 144 |
|
|
2024
Q3 | $1.28M | Buy |
44,076
+5,320
| +14% | +$155K | 0.13% | 121 |
|
|
2024
Q2 | $1.08M | Buy |
38,756
+7,169
| +23% | +$197K | 0.12% | 127 |
|
|
2024
Q1 | $877K | Buy |
31,587
+7,136
| +29% | +$198K | 0.1% | 141 |
|
|
2023
Q4 | $704K | Sell |
24,451
-1,713
| -7% | -$51.8K | 0.09% | 151 |
|
|
2023
Q3 | $868K | Sell |
26,164
-3,108
| -11% | -$110K | 0.13% | 123 |
|
|
2023
Q2 | $1.07M | Buy |
29,272
+73
| +0.3% | +$2.84K | 0.15% | 104 |
|
|
2023
Q1 | $1.19M | Buy |
29,199
+5,536
| +23% | +$239K | 0.18% | 95 |
|
|
2022
Q4 | $1.21M | Sell |
23,663
-433
| -2% | -$20.8K | 0.2% | 90 |
|
|
2022
Q3 | $1.05M | Buy |
24,096
+3,036
| +14% | +$148K | 0.2% | 89 |
|
|
2022
Q2 | $1.1M | Buy |
21,060
+854
| +4% | +$43.5K | 0.2% | 85 |
|
|
2022
Q1 | $1.05M | Buy |
20,206
+5,904
| +41% | +$306K | 0.17% | 99 |
|
|
2021
Q4 | $845K | Buy |
14,302
+293
| +2% | +$14.5K | 0.16% | 100 |
|
|
2021
Q3 | $603K | Sell |
14,009
-267
| -2% | -$11.8K | 0.13% | 110 |
|
|
2021
Q2 | $559K | Buy |
14,276
+71
| +0.5% | +$2.76K | 0.12% | 111 |
|
|
2021
Q1 | $515K | Sell |
14,205
-21,019
| -60% | -$746K | 0.12% | 103 |
|
|
2020
Q4 | $1.3M | Buy |
35,224
+1,678
| +5% | +$61.5K | 0.13% | 64 |
|
|
2020
Q3 | $1.17M | Sell |
33,546
-13,256
| -28% | -$465K | 0.14% | 62 |
|
|
2020
Q2 | $1.45M | Sell |
46,802
-5,528
| -11% | -$188K | 0.16% | 55 |
|
|
2020
Q1 | $1.62M | Buy |
52,330
+20,693
| +65% | +$705K | 0.22% | 49 |
|
|
2019
Q4 | $1.18M | Buy |
31,637
+1,035
| +3% | +$36.9K | 0.17% | 65 |
|
|
2019
Q3 | $1.04M | Sell |
30,602
-450
| -1% | -$16.4K | 0.2% | 60 |
|
|
2019
Q2 | $1.28M | Sell |
31,052
-518
| -2% | -$20.6K | 0.25% | 53 |
|
|
2019
Q1 | $1.27M | Sell |
31,570
-277
| -0.9% | -$11.1K | 0.26% | 49 |
|
|
2018
Q4 | $1.32M | Buy |
+31,847
| New | +$1.32M | 0.35% | 37 |
|
Other funds holding PFE
Magnus Financial Group's PFE Position: Q2 2026 in Review
Magnus Financial Group increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $13.4K and bringing the position to 31,451 shares worth $757K. The position accounts for 0.05% of the portfolio, ranked #190.
Magnus Financial Group first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.62M in Q1 2020. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Magnus Financial Group held 31,451 shares of Pfizer worth $757K as of Q2 2026.
- Magnus Financial Group bought 511 Pfizer shares in Q2 2026, an estimated $13.4K.
- Pfizer made up 0.05% of Magnus Financial Group's portfolio in Q2 2026, its #190 holding.
- Magnus Financial Group first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Magnus Financial Group's Pfizer position peaked at $1.62M in Q1 2020.
- 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.